ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,870.62
      -1.32%
      US Tech 100
      19,933.60
      0.36%
      Dow Jones
      43,444.99
      -0.70%
      Brent Oil
      71.575
      1.23%
      Bitcoin
      91,938.14
      2.31%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Taiwan Liposome Company Ltd (TLC) Quote

      Taiwan Liposome Company Ltd

      Taiwan Liposome Company Ltd (TLC)

      Lottery Corporation Ltd
      7.00
      0.00
      (0.00%)
      Closed November 15 4:00PM
      Delayed by 15 minutes
      7.00
      0.00
      ( 0.00% )
      Pre Market: 7:00PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      7.00
      Bid
      6.66
      Ask
      7.10
      Volume
      -
      0.00 Day's Range 0.00
      0.00 52 Week Range 0.00
      Previous Close
      7.00
      Open
      -
      Last Trade
      Last Trade Time
      -
      Average Volume (3m)
      -
      Financial Volume
      -
      VWAP
      -

      Ask ADVFN Intelligence (AI)

      TLC Latest News

      More News

      Highlights of Dr. David Hunter’s Oral Presentation at ACR’s Late Breaking Abstracts Session

      SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter, Florance and Cope Chair of Rheumatology at the University of Sydney, presented detailed...

      November 20 2023
      GlobeNewswire Inc.

      TLC to Present Phase 3 Data of TLC599 in Late-Breaking Abstracts Session at ACR

      SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

      November 08 2023
      GlobeNewswire Inc.

      TLC Announces TLC599 Agreement with Endo

      SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

      June 13 2022
      GlobeNewswire Inc.

      TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy

      SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, March 07, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target...

      March 07 2022
      GlobeNewswire Inc.

      TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares

      This communication does not constitute an offer of any securities for sale or subscription or a solicitation of an offer to purchase or subscribe to any securities in any jurisdiction. The...

      September 08 2021
      GlobeNewswire Inc.

      TLC Reports Second Quarter 2021 Financial Results and Provides Business Update

      SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 12, 2021 (GLOBE NEWSWIRE) -- TLC, a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet...

      August 12 2021
      GlobeNewswire Inc.

      TLC Announces Details of Stock Swap Transactions

      TAIPEI, Taiwan, July 05, 2021 (GLOBE NEWSWIRE) -- Taiwan Liposome Company (Nasdaq: TLC, TWO: 4152, “the company”), a clinical-stage specialty pharmaceutical company developing novel...

      July 05 2021
      GlobeNewswire Inc.

      TLC and Zydus Enter Agreement to Launch AmphoTLC™ in India

      SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 26, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

      May 26 2021
      GlobeNewswire Inc.

      TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India

      SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 25, 2021 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...

      May 25 2021
      GlobeNewswire Inc.

      InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 – Inhalable Liposome Formulations of Antiviral Drugs for COVID-1...

      SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, May 23, 2021 (GLOBE NEWSWIRE) -- InspirMed Inc., a subsidiary of TLC (Nasdaq: TLC, TWO: 4152) that specializes in the development of proprietary...

      May 23 2021
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10000000DR
      40000000DR
      120000000DR
      260000000DR
      520000000DR
      1560000000DR
      2600000000DR

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      APLMApollomics Inc
      $ 0.194
      (102.29%)
      		30.6M
      MNDRMobile health Network Solutions
      $ 0.4187
      (61.04%)
      		8.76M
      CTRNCiti Trends Inc
      $ 23.67
      (40.64%)
      		76
      CBNKCapital Bancorp Inc
      $ 38.01
      (36.48%)
      		155
      LRFCLogan Ridge Finance Corporation
      $ 33.01
      (30.47%)
      		1
      FMAOFarmers and Merchants Bancorp Inc
      $ 22.07
      (-31.61%)
      		2
      FLYEFly E Group Inc
      $ 0.4738
      (-31.26%)
      		31.73k
      CMAXCareMax Inc
      $ 1.21
      (-27.98%)
      		6.23k
      TCBXThird Coast Bancshares Inc
      $ 25.00
      (-27.70%)
      		100
      RBBRBB Bancorp
      $ 18.00
      (-26.20%)
      		100
      APLMApollomics Inc
      $ 0.194
      (102.29%)
      		30.6M
      TSLLDirexion Daily TSLA Bull 2X Trust ETF
      $ 21.58
      (15.34%)
      		10.85M
      MNDRMobile health Network Solutions
      $ 0.4187
      (61.04%)
      		8.76M
      ELABElevai Labs Inc
      $ 0.0216
      (-2.26%)
      		7.47M
      TSLATesla Inc
      $ 345.83
      (7.83%)
      		3.42M

      TLC Discussion

      View Posts
      TraderStig TraderStig 3 years ago
      #DDAmanda Chart on: $TLC

      You can scan for these before they run.



      #DDAmanda Promo Code: dsh888

      What the Fact (Factor) Column is:

      The Factor is a proprietary indicator used for scanning in #DDAmanda.

      It's defined as Today's $Traded divided by the average daily $Traded (20 day avg).

      SO, if a stock has say a 10 Factor that day, it means she traded 10 Times the $ she normally trades.

      That's significant, and many times indicates that a run in the stock is coming.




      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      $TLC READY FOR SOME NEWS .
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      $$$TLC$$$
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      https://ir.tlcbio.com/news-releases/news-release-details/tlc-announces-acceptance-manuscript-anti-covid-19-program
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      Nice close .
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      Hit me with the NEWS !!
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      4 weeks almost over, hydroxychloroquine. Study medication is administered through inhalation via a commercially available portable vibrating mesh nebulizer, and all subjects will be followed up for 4 weeks.
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      Adding .
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      This my baby, I’m adding more tomorrow .
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      https://ir.tlcbio.com/news-releases/news-release-details/tlc-announces-appointment-thomas-h-bliss-jr-mba-chief-business
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      Adding some more, updates coming soon .
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      O/S 5M one more update $10s will be up with no time .
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      https://finance.yahoo.com/news/tlc-enrolls-first-subject-phase-084100428.html
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      4K shares at $9.00 after hours !!!!
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      Huge potential !!!
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      Nice close .
      👍️0
      FROZENFLAME FROZENFLAME 4 years ago
      I’m in $$$TLC$$$
      👍️0
      crudeoil24 crudeoil24 4 years ago

      TLC Receives Australian and Taiwan Approval to Initiate Phase I Clinical Trial of TLC19 Inhalable Liposomal Hydroxychloroquine for COVID-19
      👍️0
      otcmoneydoubler otcmoneydoubler 4 years ago
      TLC MOVING ON COVID AUSTRALIAN NEWS
      👍️0

      Your Recent History

      NASDAQ
      TLC
      Taiwan Liposome
      Delayed Upgrade Clock